Terms: = Lung cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG
284 results:
1. Blocking the MIF-cd74 axis augments radiotherapy efficacy for brain metastasis in NSCLC via synergistically promoting microglia M1 polarization.
Liu L; Wang J; Wang Y; Chen L; Peng L; Bin Y; Ding P; Zhang R; Tong F; Dong X
J Exp Clin Cancer Res; 2024 Apr; 43(1):128. PubMed ID: 38685050
[TBL] [Abstract] [Full Text] [Related]
2. Prognosis stratification of cancer patients treated with immune checkpoint inhibitors through lung immune prognostic index: a meta-analysis and systematic review.
Guo Y; Pan Y; Wan J; Gong B; Li Y; Kan X; Zheng C
BMC Cancer; 2024 Apr; 24(1):523. PubMed ID: 38664760
[TBL] [Abstract] [Full Text] [Related]
3. Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study.
Kim DW; Chul Cho B; Pachipala K; Kim SW; Wang CL; Chang GC; Ahn MJ; Alvarez R; Chiu CH; Trigo J; Estival A; Karam SD; O'Brien C; Gowda H; Jiang H; Bauman JE
Lung Cancer; 2024 Apr; 190():107530. PubMed ID: 38471416
[TBL] [Abstract] [Full Text] [Related]
4. Lipidomics reveals new lipid-based lung adenocarcinoma early diagnosis model.
Sun T; Chen J; Yang F; Zhang G; Chen J; Wang X; Zhang J
EMBO Mol Med; 2024 Apr; 16(4):854-869. PubMed ID: 38467839
[TBL] [Abstract] [Full Text] [Related]
5. Mechanisms of Resistance to Tyrosine Kinase Inhibitors in ROS1 Fusion-Positive Nonsmall Cell lung cancer.
Zhao X; Zhang X; Chen H; Bao H; Wu X; Wang H; Bao H; Pang J; Wang S; Wang J
Clin Chem; 2024 Apr; 70(4):629-641. PubMed ID: 38416709
[TBL] [Abstract] [Full Text] [Related]
6. Deciphering the heterogeneity of neutrophil cells within circulation and the lung cancer microenvironment pre- and post-operation.
Liu F; Liu X; Liu Y; Chen D; Liu X; Qin C; Song Y; Fang H; Wu D
Cell Biol Toxicol; 2024 Feb; 40(1):11. PubMed ID: 38319415
[TBL] [Abstract] [Full Text] [Related]
7. PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores.
Ivanova M; Frascarelli C; Cerbelli B; Pignataro MG; Pernazza A; Venetis K; Sajjadi E; Criscitiello C; Curigliano G; Guerini-Rocco E; Graziano P; Martini M; d'Amati G; Fusco N
Hum Pathol; 2024 Feb; 144():22-27. PubMed ID: 38278450
[TBL] [Abstract] [Full Text] [Related]
8. cd74-ROS1 L2026M mutant enhances autophagy through the MEK/ERK pathway to promote invasion, metastasis and crizotinib resistance in non-small cell lung cancer cells.
Xu X; Li Y; Xu R; Meng Y; Li Z; Zuo D; Wu Y
FEBS J; 2024 Mar; 291(6):1199-1219. PubMed ID: 38148635
[TBL] [Abstract] [Full Text] [Related]
9. cd74/SLC34A2-ROS1 Fusion Variants Involving the Transmembrane Region Predict Poor Response to Crizotinib in NSCLC Independent of TP53 Mutations.
Li W; Fei K; Guo L; Wang Y; Shu C; Wang J; Ying J
J Thorac Oncol; 2024 Apr; 19(4):613-625. PubMed ID: 38070598
[TBL] [Abstract] [Full Text] [Related]
10. The Association between ER, PR, HER2, and ER-/PR+ Expression and lung cancer Subsequent in Breast cancer Patients: A Retrospective Cohort Study Based on SEER Database.
Shao HY; Hao BT; Gao FX
Breast J; 2023; 2023():7028189. PubMed ID: 38021219
[TBL] [Abstract] [Full Text] [Related]
11. Association of antibiotic exposure with survival in patients with extensive-stage small cell lung cancer receiving immune checkpoint inhibitor therapy.
Zhong J; Xiong D; Liu Y; Yuan S
Thorac Cancer; 2024 Jan; 15(2):152-162. PubMed ID: 38010059
[TBL] [Abstract] [Full Text] [Related]
12. Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON).
Garon EB; Cho BC; Luft A; Alatorre-Alexander J; Geater SL; Kim SW; Ursol G; Hussein M; Lim FL; Yang CT; Araujo LH; Saito H; Reinmuth N; Medic N; Mann H; Shi X; Peters S; Mok T; Johnson M
Lung Cancer; 2023 Dec; 186():107422. PubMed ID: 37992595
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of cd74 Occurrence in Oncogenic Fusion proteins.
Vargas J; Pantouris G
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958963
[TBL] [Abstract] [Full Text] [Related]
14. Intrinsic resistance to ROS1 inhibition in a patient with cd74-ROS1 mediated by AXL overexpression.
Peters TL; Chen N; Tyler LC; Le AT; Dimou A; Doebele RC
Thorac Cancer; 2023 Nov; 14(33):3259-3265. PubMed ID: 37727007
[TBL] [Abstract] [Full Text] [Related]
15. Updated risk models for lung cancer due to radon exposure in the German Wismut cohort of uranium miners, 1946-2018.
Kreuzer M; Deffner V; Sommer M; Fenske N
Radiat Environ Biophys; 2023 Nov; 62(4):415-425. PubMed ID: 37695330
[TBL] [Abstract] [Full Text] [Related]
16. Revealing the role of regulatory T cells in the tumor microenvironment of lung adenocarcinoma: a novel prognostic and immunotherapeutic signature.
Zhang P; Zhang X; Cui Y; Gong Z; Wang W; Lin S
Front Immunol; 2023; 14():1244144. PubMed ID: 37671160
[TBL] [Abstract] [Full Text] [Related]
17. New cancer Diagnoses Before and During the COVID-19 Pandemic.
Decker KM; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Pitz M; Singh H; Thiessen M; Lambert P
JAMA Netw Open; 2023 Sep; 6(9):e2332363. PubMed ID: 37669049
[TBL] [Abstract] [Full Text] [Related]
18. A case of cd74-ROS1-positive lung adenocarcinoma diagnosed by next-generation sequencing achieved long-term survival with pemetrexed regimens.
Tanaka S; Yoshimura N; Asakawa R; Tobita S; Yaga M; Ueno K
Thorac Cancer; 2023 Sep; 14(25):2618-2621. PubMed ID: 37488715
[TBL] [Abstract] [Full Text] [Related]
19. Next Generation Sequencing Analysis and its Benefit for Targeted Therapy of lung Adenocarcinoma.
Kulda V; Polivka J; Svaton M; Vanecek T; Buresova M; Houfkova K; Bagheri MS; Knizkova T; Vankova B; Windrichova J; Macan P; Babuska V; Pesta M
Cancer Genomics Proteomics; 2023; 20(4):404-411. PubMed ID: 37400146
[TBL] [Abstract] [Full Text] [Related]
20. Discovery of novel 2-aminopyridine derivatives as ROS1 and ALK dual inhibitors to combat drug-resistant mutants including ROS1
Liu S; Huang C; Huang C; Huang Y; Yu Y; Wu G; Guo F; Jiang Y; Wan S; Zhu Z; Tian Y; Zhu J; Zhang J
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2227779. PubMed ID: 37349867
[TBL] [Abstract] [Full Text] [Related]
[Next]
